A conversation between neonatal neurologists, Drs. Janet Soul and Tauen Chang.
Neonatal Seizure Trials: what have we learned? (Organizer: Janet Soul, MD)
Janet Soul, MD
Janet Soul completed an internship and residency at Boston City Hospital and, subsequently, fellowships in neurology and neonatal neurology at Boston Children’s Hospital. She is an Associate Professor in Neurology at Harvard Medical School. Her research focus is on acquired brain injury in newborn infants, with particular interest in hypoxic-ischemic brain injury, involving a lack of oxygen and blood flow to the brain; the treatment of seizures in term newborns; and periventricular leukomalacia (injury to the white matter of the brain) intraventricular hemorrhage (bleeding into the ventricles of the brain) and hydrocephalus in preterm newborns.
Dr. Soul has been actively involved in the CNS throughout her training and academic career, including multiple “tours of duty” on the Scientific Program Planning Committee and as organizer and/or speaker of several seminars and symposia focused on newborn neurology. Fittingly, she received the 1998 Outstanding Junior Member Award in 1998 at the CNS Annual Meeting in Montreal, mere blocks away from where she received her medical school training at McGill University.
Tauen Chang, MD
Taeun Chang, MD is the Director of the Neonatal Neurology and Neonatal Critical Care (NNCC) Program in the division of Neurophysiology, Epilepsy and Critical Care at Children’s National Health System in Washington, DC. Dr. Chang and her colleague, Tammy Tsuchida, MD established an internationally-renowned neonatal neuromonitoring unit with four digital video EEG monitors in the NICU and bedside remote EEG access to each NICU bed. The NNCC service performs more than 400 prolonged continuous video-EEGs per year in our NICU (over 3,000 continuous EEG recordings since 2006); identifies more than 60 newborns per year with seizures as a result of hypoxic ischemic encephalopathy, perinatal strokes, cerebral dysgenesis, infection, inborn errors of metabolism or infantile epilepsy disorders; led national committees to establish neonatal EEG monitoring guidelines and terminologies; and collaborates on multiple national study groups for neonatal EEG, seizures and seizure treatment trials.
Dr. Chang received her medical degree from Children’s National and George Washington University School of Medicine and completed her pediatric residency at Children’s Hospital of Pittsburgh before returning to Children’s National for her child neurology fellowship and, subsequently, faculty appointment in child neurology.